Intestinal Research

Inflammatory bowel diseases
Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models: Emiko Mizoguchi, Daren Low, Yui Ezaki, Toshiyuki Okada; Intest Res. 2020;18(2):151-167. Published online April 20, 2020; DOI: https://doi.org/10.5217/ir.2019.09154
Cited By 45; Full text PubReader ePub Crossref - TDM PDF

Novel biomarkers for the diagnosis and prognosis of colorectal cancer: Hyung-Hoon Oh, Young-Eun Joo; Intest Res. 2020;18(2):168-183. Published online November 30, 2019; DOI: https://doi.org/10.5217/ir.2019.00080
Cited By 31; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Fibrostenotic strictures in Crohn’s disease: Jun Hwan Yoo, Stefan Holubar, Florian Rieder; Intest Res. 2020;18(4):379-401. Published online April 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09148
Cited By 20; Full text PubReader ePub Crossref - TDM PDF

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases: Jung Min Kim, Jae Hee Cheon; Intest Res. 2020;18(3):249-264. Published online April 18, 2020; DOI: https://doi.org/10.5217/ir.2019.00128
Cited By 19; Full text PubReader ePub Crossref - TDM PDF

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease: Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, Jae Min Lee, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim; Intest Res. 2020;18(1):79-84. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00107
Cited By 18; Full text PubReader ePub Crossref - TDM PDF

Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases: Julajak Limsrivilai, Nonthalee Pausawasdi; Intest Res. 2021;19(1):21-32. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.09142
Cited By 15; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study: Jamilya Kaibullayeva, Aliya Ualiyeva, Ainash Oshibayeva, Anar Dushpanova, John K. Marshall; Intest Res. 2020;18(4):430-437. Published online September 29, 2020; DOI: https://doi.org/10.5217/ir.2019.00099
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion: Kenji Watanabe; Intest Res. 2020;18(4):347-354. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00032
Cited By 13; Full text PubReader ePub Crossref - TDM PDF

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases: Sang Hyoung Park, Jae Cheol Park, Milan Lukas, Martin Kolar, Edward V. Loftus, Jr; Intest Res. 2020;18(1):34-44. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09147
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease: Katsuyoshi Matsuoka; Intest Res. 2020;18(3):275-281. Published online June 3, 2020; DOI: https://doi.org/10.5217/ir.2020.00002
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis: Shinta Mizuno, Keiko Ono, Yohei Mikami, Makoto Naganuma, Tomohiro Fukuda, Kazuhiro Minami, Tatsuhiro Masaoka, Soichiro Terada, Takeshi Yoshida, Keiichiro Saigusa, Norimichi Hirahara, Hiroaki Miyata, Wataru Suda, Masahira Hattori, Takanori Kanai; Intest Res. 2020;18(1):69-78. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00084
Cited By 11; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Inflammatory Bowel Diseases
Quality of life in inflammatory bowel diseases: it is not all about the bowel: Ronald Keller, Nazar Mazurak, Laura Fantasia, Stefano Fusco, Nisar P Malek, Jan Wehkamp, Paul Enck, Thomas Klag; Intest Res. 2021;19(1):45-52. Published online February 27, 2020; DOI: https://doi.org/10.5217/ir.2019.00135
Cited By 10; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Inflammatory bowel diseases
Differentiation of fibrotic and inflammatory component of Crohn’s disease-associated strictures: Jordi Rimola, Nunzia Capozzi; Intest Res. 2020;18(2):144-150. Published online April 20, 2020; DOI: https://doi.org/10.5217/ir.2020.00015
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Functional bowel disorder
Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease: Antigony Mitselou, Vasileios Grammeniatis, Anna Varouktsi, Stamatis S Papadatos, Konstantinos Katsanos, Vasiliki Galani; Intest Res. 2020;18(1):115-120. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00125
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Inflammatory Bowel Diseases
Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease: Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja; Intest Res. 2021;19(3):291-300. Published online May 26, 2020; DOI: https://doi.org/10.5217/ir.2019.09172
Cited By 9; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Most cited